Publications by authors named "Jonathan L Carter"

Claim this Profile
A
Author Correction: Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls.
Catherine E Oliver, Jonathan L Carter, James S Hong, Mingzhi Xu, William E Kraus

Commun Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls.
Catherine E Oliver, Jonathan L Carter, James S Hong, Mingzhi Xu, William E Kraus

Commun Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral enhancement in MOG antibody-associated disease.
Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch, Jonathan L Carter

J Neurol Neurosurg Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review.
Paul M Elsbernd, Jonathan L Carter

Biologics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review.
Paul M Elsbernd, William R Hoffman, Jonathan L Carter, Dean M Wingerchuk

Mult Scler Relat Disord· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis.
Cristina Valencia-Sanchez, Jonathan L Carter

Expert Opin Pharmacother· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations.
Cristina Valencia-Sanchez, Brent P Goodman, Jonathan L Carter, Dean M Wingerchuk

Mult Scler· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Andrew J Solomon, Dennis N Bourdette, Anne H Cross, Angela Applebee, Philip M Skidd, Jonathan L Carter

Neurology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alliance for clinical education perspective paper: recommendations for redesigning the "final year" of medical school.
Shalini T Reddy, Jason Chao, Jonathan L Carter, Robert Drucker, Nadine T Katz

Teach Learn Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of neurology medical school education: results of 2005 and 2012 clerkship director survey.
Jonathan L Carter, Imran I Ali, Richard S Isaacson, Joseph E Safdieh, Glen R Finney

Neurology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Shruti P Agnihotri, Xin Dang, Jonathan L Carter, Terry D Fife, Evelyn Bord

Neurology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Dean M Wingerchuk, Jonathan L Carter

Mayo Clin Proc· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosis.
Greg M Thaera, Dean M Wingerchuk, Jonathan L Carter

Mult Scler Relat Disord· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination.
Reem F Bunyan, Bogdan F Gh Popescu, Jonathan L Carter, Richard J Caselli, Joseph E Parisi

Arch Neurol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care reform legislation: momentous implications for shaping pharmacy's future.
Cynthia J Boyle, Raymond C Love, Leticia R Moczygemba, Jonathan L Carter, Kristen Zeitler

J Am Pharm Assoc (2003)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic.
Srijana Zarkou, Jonathan L Carter, Kay E Wellik, Bart M Demaerschalk, Dean M Wingerchuk

Neurologist· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do cannabinoids reduce multiple sclerosis-related spasticity?
Greg M Thaera, Kay E Wellik, Jonathan L Carter, Bart M Demaerschalk, Dean M Wingerchuk

Neurologist· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical consultations: multiple sclerosis.
Dean M Wingerchuk, Jonathan L Carter

Semin Neurol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis